W2O Group
W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We work with clients to craft their positioning, strategy, and messaging, as well as supporting connection with customers across multiple communication channels.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
EatMoreFruit
Welcome to EatMoreFruit – a top 10 independent global healthcare communications agency based in the heart of London. Specialising in PR, digital, influencer & communication services, we deliver creative &…
Four Agency Worldwide
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
MDNT
MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Resonant Group
Resonant Group is an award-winning group of agencies driven by the same core values and a common belief that lives can be transformed through better health communication.
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Pegasus Moves to Brighton
Press Releases | April 29, 2014 | Inizio
Top UK Healthcare Communications Consultancy Moves to Brighton
UX: Designing Human Experiences
White Papers and Resources | April 24, 2014 | Havas Lynx
Applying science to the creative process to improve lives
08 UX: Pushing the right buttons
White Papers and Resources | March 31, 2014 | Havas Lynx
Unlocking better outcomes in healthcare with UX
UX: Pushing the right buttons
White Papers and Resources | March 31, 2014 | Havas Lynx
Unlocking better outcomes in healthcare with UX
07 Good Pharma
White Papers and Resources | January 3, 2014 | Havas Lynx
Better for patients, better for business
06 Our Opportunity to Rethink the Health Experience
White Papers and Resources | January 3, 2014 | Havas Lynx
Our point of view
05 Social Media: A Health Hazard?
White Papers and Resources | January 3, 2014 | Havas Lynx
The case to embrace going social
Creating a Lifeline to the New Digital User
White Papers and Resources | January 3, 2014 | Havas Lynx
Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...
Warehousing of HCV patients reaches new high
White Papers and Resources | December 19, 2013 | Inizio
A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...
Brand leaders in RA will lose market share, predict rheumatologists
White Papers and Resources | December 19, 2013 | Inizio
Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.